Table 15.5a

Steroid Avoidance Rate at Discharge, 1995 to 2004

Recipients of Deceased Donor Livers

Discharge Regimen Year of Transplant
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Total Patients 2,983 2,981 3,026 3,357 3,417 3,621 3,751 4,061 4,443 4,856
Steroids Avoided 362 247 153 179 242 297 370 408 769 956
Rate 12.1% 8.3% 5.1% 5.3% 7.1% 8.2% 9.9% 10.0% 17.3% 19.7%
CyA Patients 516 392 513 525 371 226 117 97 76 57
Steroids Avoided 73 33 27 59 35 6 18 11 20 10
Rate 14.1% 8.4% 5.3% 11.2% 9.4% 2.7% 15.4% 11.3% 26.3% 17.5%
Tac Patients 967 929 1,047 1,298 1,379 1,196 1,343 1,646 1,640 1,755
Steroids Avoided 55 40 49 67 80 52 131 197 331 490
Rate 5.7% 4.3% 4.7% 5.2% 5.8% 4.3% 9.8% 12.0% 20.2% 27.9%
CyA+MMF Patients 54 220 197 237 315 258 212 186 179 191
Steroids Avoided 11 19 13 4 9 11 7 8 19 39
Rate 20.4% 8.6% 6.6% 1.7% 2.9% 4.3% 3.3% 4.3% 10.6% 20.4%
Tac+MMF Patients 101 393 501 711 881 1,204 1,431 1,595 2,057 2,313
Steroids Avoided 6 28 24 21 56 95 106 124 284 299
Rate 5.9% 7.1% 4.8% 3.0% 6.4% 7.9% 7.4% 7.8% 13.8% 12.9%
CyA+Aza Patients 762 522 323 210 146 109 51 56 24 52
Steroids Avoided 27 31 4 5 12 1 0 6 22 26
Rate 3.5% 5.9% 1.2% 2.4% 8.2% 0.9% 0.0% 10.7% 91.7% 50.0%
Tac+Aza Patients 236 223 154 163 99 75 65 88 100 47
Steroids Avoided 8 5 1 2 5 3 4 2 13 19
Rate 3.4% 2.2% 0.6% 1.2% 5.1% 4.0% 6.2% 2.3% 13.0% 40.4%
Siro+MMF Patients - 1 - - 2 28 48 46 43 42
Steroids Avoided - 0 - - 0 1 0 3 8 5
Rate - 0.0% - - 0.0% 3.6% 0.0% 6.5% 18.6% 11.9%
CyA+Siro Patients - - - 26 3 37 25 26 24 23
Steroids Avoided - - - 5 0 24 16 1 0 2
Rate - - - 19.2% 0.0% 64.9% 64.0% 3.8% 0.0% 8.7%
Tac+Siro Patients - - - - 4 193 197 107 53 85
Steroids Avoided - - - - 0 34 33 15 7 22
Rate - - - - 0.0% 17.6% 16.8% 14.0% 13.2% 25.9%
Other Regimen Patients 347 301 291 187 217 295 262 214 247 291
Steroids Avoided 182 91 35 16 45 70 55 41 65 44
Rate 52.4% 30.2% 12.0% 8.6% 20.7% 23.7% 21.0% 19.2% 26.3% 15.1%


Source: OPTN/SRTR Data as of May 2, 2005.

Includes patients receiving first transplants of any organ with a functioning graft at discharge and any immunosuppressivedrug use recorded at discharge.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine;Siro: Sirolimus.